What's new

Human medicines European public assessment report (EPAR): Yorvipath, palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Yorvipath, palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 5, Status: Authorised

Jun 20, 2025 - 13:45
 0
Human medicines European public assessment report (EPAR): Yorvipath, palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Yorvipath, palopegteriparatide, Date of authorisation: 17/11/2023, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

EMEA-003600-PIP01-24

Next Article

Human medicines European public assessment report (EPAR): Axura, memantine, Date...

Related Posts

EMEA-003567-PIP01-23

EMEA-003567-PIP01-23

Jun 11, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Koselugo, Selumetinib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Congenital, familial and genetic disorders, PIP number: P/0134/2024

Opinion/decision on a Paediatric investigation plan (PI...

Jun 10, 2025  0

Human medicines European public assessment report (EPAR): Afiveg, aflibercept, Status: Opinion

Human medicines European public assessment report (EPAR...

Jun 20, 2025  0